BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21395143)

  • 1. [Comparative evaluation of the hemodynamic effect of 6% hydroxyethyl starch 130/0.42 solution versus 4% modified liquid gelatin solution in cardiosurgical patients].
    Eremenko AA; Safarov PN
    Anesteziol Reanimatol; 2010; (5):49-52. PubMed ID: 21395143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness and safety of using 6% hydroxyethyl starch 130/04 and 4% modified liquid gelatin in neurosurgical patients with massive intraoperative blood loss].
    Israelian LA; Lubnin AIu
    Anesteziol Reanimatol; 2009; (5):42-8. PubMed ID: 20491145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative study of the effectiveness of 5% human albumin and 10% hydroxyethyl starch (HAES-steril) for correcting hemodynamics and O2 transport in surgical interventions].
    Hankeln K; Senker R; Beez M; Gol'dina OA
    Anesteziol Reanimatol; 1997; (1):23-6. PubMed ID: 9173811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass.
    Boldt J; Lehmann A; Römpert R; Haisch G; Isgro F
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):264-8. PubMed ID: 10890478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Using solutions of hydroxyethyl starch (6% HES 200/0.5 (refortan) and 6% HES 130/0.4 (voluven)) in neuroanesthesiology].
    Kondrat'ev AN; Novikov VIu; Savvina IA; Driagina NV
    Anesteziol Reanimatol; 2008; (2):27-30. PubMed ID: 18543426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
    Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
    J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch].
    Hopf HB; Siepmann HP
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.
    Thaler U; Deusch E; Kozek-Langenecker SA
    Anaesthesia; 2005 Jun; 60(6):554-9. PubMed ID: 15918826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the intraoperative effectiveness of 5% human albumin or 10% hydroxyethyl starch (HAES-steril) on hemodynamics and oxygen transport in 40 patients].
    Hankeln K; Senker R; Beez M
    Infusionstherapie; 1990 Jun; 17(3):135-40. PubMed ID: 1697283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Colloidal hypertonic solutions in cardiac surgery].
    Boldt J; Hammermann H; Hempelmann G
    Zentralbl Chir; 1993; 118(5):250-6. PubMed ID: 7686706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
    London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
    J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiorespiratory and microcirculatory effects following volume replacement using a new hydroxyethyl starch preparation].
    Boldt J; Knothe C; Zickmann B; Ballesteros M; Zeiler D; Dapper F; Hempelmann G
    Anaesthesist; 1992 Jun; 41(6):316-23. PubMed ID: 1379009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
    Penner M; Fingerhut D; Tacke A
    Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
    Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
    Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertonic-hyperoncotic volume replacement (7.5% NaCl/10% hydroxyethyl starch 200.000/0.5) in patients with coronary artery stenoses].
    Prien T; Thülig B; Wüsten R; Schoofs J; Weyand M; Lawin P
    Zentralbl Chir; 1993; 118(5):257-63; discussion 264-6. PubMed ID: 7686707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hydroxyethyl starch resuscitation on extravascular lung water and pulmonary permeability in sepsis-related acute respiratory distress syndrome.
    Huang CC; Kao KC; Hsu KH; Ko HW; Li LF; Hsieh MJ; Tsai YH
    Crit Care Med; 2009 Jun; 37(6):1948-55. PubMed ID: 19384203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
    Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
    Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W; Pölz W; Colombo T; Steindorfer P
    Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients.
    Van der Linden PJ; De Hert SG; Daper A; Trenchant A; Schmartz D; Defrance P; Kimbimbi P
    Can J Anaesth; 2004 Mar; 51(3):236-41. PubMed ID: 15010405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.